In conclusion, we have identified ZEB1 as a bona fide target of FOXE1 in thyroid cancer cells, which provides new insights into the role of FOXE1 in regulating EMT in thyroid cancer. This evidence concerns the gene FOXE1 and thyroid gland carcinoma.